LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2013

Mar 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2013-02-28

Reporting Person: ZAMBROWICZ BRIAN P (EVP, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-28	Common Stock	M	21250	—	Acquired	224331	Direct
2013-02-28	Common Stock	M	21500	—	Acquired	245831	Direct
2013-02-28	Common Stock	F	11692	$1.98	Disposed	234139	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-28	Restricted Stock Units (Phantom Stock)	$	M	21250	Disposed		Common Stock (21250)	Direct
2013-02-28	Restricted Stock Units (Phantom Stock)	$	M	21500	Disposed		Common Stock (21500)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2012 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F4: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.